Multaq
Multaq (dronedarone) is an antiarrhythmic drug used to maintain normal sinus rhythm in patients with a history of atrial fibrillation or atrial flutter. It works by affecting the electrical activity of the heart muscle, specifically by blocking potassium, sodium, and calcium channels.
Dosage by Body Weight
The standard adult dose of Multaq is 400 mg taken twice daily with morning and evening meals. It is not prescribed to pediatric patients, and dosing is not adjusted by body weight.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness in pediatric patients under 18 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 5-7 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 8-10 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 11-15 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
| 16-20 kg | Not recommended | Do not use | Safety and effectiveness in pediatric patients under 18 years of age have not been established. |
Formulation
Tablet
Purpose
Used to reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF.
Generic Name
DronedaroneScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.